ECDC includes guidance on hepatitis and HIV testing



The ECDC Guidelines propose an attempt to carry out test strategies or coherent programs for hepatitis B (HBV), hepatitis C (HCV) and HIV to try to reduce the large number of people who at present but not confirmed. Such integrated strategies or test programs should therefore implement the six key principles of testing and respect the individual needs of those who have been tested:

  • Test should be accessible, voluntary, confidential and include informed consent.
  • Appropriate information should be available before and after exams.
  • Care is an integral part of an effective test program.
  • Updating HBV, HCV and HIV tests in all healthcare settings; and
  • Those who make HIV, HBV and / or HCV tests should receive appropriate training and education.
  • An effective national testing strategy, including a monitoring and evaluation framework, is essential in the & # 39; treating HBV, HCV and HIV disease.

Success in increasing the test level should be & # 39; greatly contributing to the abolition of HIV and a & # 39; fighting viral hepatitis as a public health threat by 2030 as defined in the Sustainable Development Goals.

The ECDC Guidance describes who, where, how and when it needs a test for viral hepatitis and HIV and its; offers options for test strategies that are relevant to all healthcare and further afield (for example self-sampling and self-testing). As a result of a higher risk of disease, population groups that are suitable for HBV, HCV and / or HIV tests include, among others, men with genes with men, homeless people , gender workers, people who taking drugs, women who are pregnant with a child or a hemodialysis patient. Examples of best practice in the Guidance include the provision of methods for healthcare, hospital, HIS clinics, pharmacies, prisons as well as community settings, and facilities; including drug reduction services and harm.

Unified test: health benefits and "unions at times of resource constraints"

"If we want to increase the benefits of HIV or viral hepatitis, it is crucial to prove and test people as quickly as possible during their disease. This is challenging because the Three diseases can be unusual for years. According to ECDC estimates, it is currently taking three years from the time of HIV infection to be judged. That's too long, "said -near ECDC Director Andrea AmmonThe Post Office "Our new test guidance offers a range of evidence-based options for interventions planning national or local examinations for different situations and at risk numbers. One of the key elements of testing services can be differentiated and combined as this allows opportunity to work together at times of resource constraints. "

Early diagnosis and commitment to provide strong and individual benefits to individuals: the effective healing of HIV or viral hepatitis can be seen; eliminate viruses or severely block the virus; means that those treated have prevented transmission chains; already preventing further diseases.

However, too many people living with HIV or acute hepatitis B in the EU / EEA are aware of their disease – and so they do not. be treated.

Vytenis Andriukaitis, European Commissioner for Health and Food Safety, said: "An increase in antiretroviral cure has changed the nature of HIV infection in Europe – there is no longer disease in HIV. For people who have been tested early and have effective cure, HIV has being a continuous state. Progress in rigorous test attempts over the last ten years, estimates show that there is still no proof of one of the seven who are living with HIV in the EU / EEA. We need to focus our efforts on the reach of these people, and especially those that are most vulnerable in society. We also need to strive for our efforts in test for hepatitis B and C; diseases that are estimated to affect 9 million people in the European Union. We need to deal with these three diseases, if we meet our Sustainable Development target . The European Commission strongly supports the European Test Week. "

A European Experience Week is currently beginning with more than 700 organizations across Europe and Central Asia. Encourage dialogue among those who may benefit from being tested and those who carry out tests – as a result of early diagnosis of HIV and viral hepatitis, benefit everyone.


Source link